Genzyme in hostile takover bid by Sanofi-Aventis
French drugmaker Sanofi-Aventis has begun a hostile takeover of Massachusetts-based Genzyme.
The offer values the US biotechnology firm at $18.5bn.
It is the biggest hostile takeover attempt in the pharmaceutical industry for two years.
Juliana Liu reports from New York.
04 Oct 2010
- From the section Business